AlphaValue Corporate Services
This research has been commissioned and paid for by the company and is deemed to constitute an acceptable minor non-monetary benefit as defined in MiFID II

Crossject

CR
Bloomberg   ALCJ FP
Supergenerics  /  France  Web Site   |   Investors Relation
Things get going
Pension matters

At year-end 2022, Crossject employed 102 people (99 in 2021,97 in 2020, 79 in 2019, 72 in 2018, 59 employees in 2017, 39 in FY16 and 23 in FY15). We expect this number to rise, although we have considered that all NTEs under development will be marketed through partnerships, which does not require a significant workforce. Of course, the situation could be different if the group decided to change this marketing policy in the future, although we don’t believe Crossject will market its products on its own in the foreseeable future.

Summary
  • Summary
  • Geo. Liabilities
  • Inputs
Plans
  • Funded Oblig.
  • Plan Assets
  • Unfund. Obligations
Impacts
  • B/S Impact
  • P&L Impact
  • Corridors
Target
Upside 154%
Price (€) 4.63
Market Cap (€M) 169
Export all
Changes to Forecasts : 25/07/2023.